Table 8.
Variable | Treated PD subjects (N = 284) |
---|---|
Class of dopaminergic therapya | |
Dopamine replacements | 85 (31.60%) |
Dopamine agonists | 65 (24.16%) |
COMT inhibitors | 0 (0.00%) |
Mao‐B inhibitors | 106 (39.41%) |
Anti‐cholinergics | 2 (0.74%) |
Other (amantadine, apomorphine SQ) | 21 (7.81%) |
Missing | 15 |
Note: Subjects may have more than one class of DT listed.
Report generated on data submitted as of: 15 September 2014.